Mariana Bastos‐Oreiro

Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma

Mi Kwon, Gloria Iacoboni, Juan Luis Reguera et al. · Haematologica · 2022 · 132 citations · Full text

Medicine, Hematology, Oncology +13

Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy

Gloria Iacoboni, Vı́ctor Navarro, Ana África Martín‐López et al. · Journal of Clinical Oncology · 2023 · 125 citations · Full text

Medicine, Immunology, Oncology +14

Validation of the <scp>NCCN</scp>‐<scp>IPI</scp> for diffuse large B‐cell lymphoma (<scp>DLBCL</scp>): the addition of β₂‐microglobulin yields a more accurate <scp>GELTAMO</scp>‐<scp>IPI</scp>

Carlos Montalbán, Antonio Díaz‐López, Iván Dlouhy et al. · British Journal of Haematology · 2017 · 82 citations · Full text

Medicine, Oncology, Cancer Immunology +13

Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study

Isabel Regalado‐Artamendi, Ana Jiménez Ubieto, José‐Ángel Hernández‐Rivas et al. · HemaSphere · 2021 · 76 citations · Full text

Medicine, Hematology, Oncology +11

Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation

Mariana Bastos‐Oreiro, Ana Pérez‐Corral, Carolina Martínez‐Laperche et al. · European Journal Of Haematology · 2014 · 71 citations

Medicine, Hematology, Oncology +16